In addition, expressions of MCT1, GPR109A, as well as GPR109Bproteins were studied in the patient-derived glioblastoma stem celllines BT11, BT12, BT27, S24, and ZH305 by Western Blot analysis (Figure B). This evidence concerns the gene SLC16A1 and glioblastoma.